跳至主要内容
临床试验/EUCTR2010-022393-13-NL
EUCTR2010-022393-13-NL进行中(未招募)不适用

Does helium protect the heart against ischaemia-reperfusion damage in patients with acute myocardial infarction? - Helium-MI

Academical Medical Center, University of Amsterdam0 个研究点目标入组 70 人开始时间: 2010年8月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ST-elevation myocardial infarction, which will be treated by primary PCI
  • Chest pain of less then 12 hours duration
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Left bundle branch block
  • Previous MI
  • Fibrinolytic treatment in the previous 30 days
  • Prior coronary artery bypass grafting surgery
  • Left main stenosis, requiring coronary artery bypass grafting surgery
  • Severe heart failure, as witnessedby any of the folowing: need for mechinal ventilation, need for an intra-aortic balloon bup or Impella, or the need of high dosage of catechomalines
  • Use of glibenclamide
  • Kidney failure
  • A contraindication for MRI

研究者

相似试验

Does helium protect the heart against... | 临床试验